Imidazopyrazines as protein kinase inhibitors
    35.
    发明授权
    Imidazopyrazines as protein kinase inhibitors 失效
    咪唑吡嗪作为蛋白激酶抑制剂

    公开(公告)号:US07557104B2

    公开(公告)日:2009-07-07

    申请号:US11758243

    申请日:2007-06-05

    IPC分类号: A61K31/497

    CPC分类号: C07D487/04

    摘要: In its many embodiments, the present invention provides a novel class of imidazopyrazine compounds as inhibitors of protein and/or checkpoint kinases, methods of preparing such compounds, pharmaceutical compositions including one or more such compounds, methods of preparing pharmaceutical formulations including one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the protein or checkpoint kinases using such compounds or pharmaceutical compositions.

    摘要翻译: 在其许多实施方案中,本发明提供了一类新颖的咪唑并吡嗪化合物作为蛋白质和/或检查点激酶的抑制剂,制备此类化合物的方法,包含一种或多种此类化合物的药物组合物,制备药物制剂的方法,包括一种或多种 化合物,以及使用这些化合物或药物组合物治疗,预防,抑制或改善与蛋白质或检查点激酶相关的一种或多种疾病的方法。

    Heterocyclic Kinase Inhibitors: Methods of Use and Synthesis
    37.
    发明申请
    Heterocyclic Kinase Inhibitors: Methods of Use and Synthesis 审中-公开
    杂环激酶抑制剂:使用和合成方法

    公开(公告)号:US20080119515A1

    公开(公告)日:2008-05-22

    申请号:US10547959

    申请日:2004-03-10

    CPC分类号: C07D401/06 C07D405/14

    摘要: Inhibitors of kinases, compositions including the inhibitors, and methods of using the inhibitors and inhibitor compositions are described. The inhibitors and compositions including them are useful for treating disease or disease symptoms. The invention also provides for methods of making kinase inhibitor compounds, methods of inhibiting kinase activity, and methods for treating disease or disease symptom.

    摘要翻译: 描述了激酶抑制剂,包括抑制剂的组合物,以及使用抑制剂和抑制剂组合物的方法。 包括它们的抑制剂和组合物可用于治疗疾病或疾病症状。 本发明还提供了制备激酶抑制剂化合物的方法,抑制激酶活性的方法,以及治疗疾病或疾病症状的方法。